| 6652 | N | 207932 | 006 | BUPRENORPHINE HYDROCHLORIDE | FILM;BUCCAL | FILM | BUCCAL | BELBUCA | BDSI | EQ 0.75MG BASE | | [] | 2015-10-23 | Oct 23, 2015 | No | Yes | No | RX | BIODELIVERY SCIENCES INTERNATIONAL INC | 2d9ac527399945a01ac889d070beac308a8fa4c8985151a7984c4695ac47dc34 |
| 6653 | N | 207932 | 007 | BUPRENORPHINE HYDROCHLORIDE | FILM;BUCCAL | FILM | BUCCAL | BELBUCA | BDSI | EQ 0.9MG BASE | | [] | 2015-10-23 | Oct 23, 2015 | No | Yes | Yes | RX | BIODELIVERY SCIENCES INTERNATIONAL INC | ca5a05f1dbeb648bf1bd926262e39d7a05301b91810c9202f256d30dc84cb068 |
| 6654 | N | 205637 | 001 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL | FILM | BUCCAL | BUNAVAIL | BDSI | EQ 2.1MG BASE;EQ 0.3MG BASE | | [] | 2014-06-06 | Jun 6, 2014 | No | Yes | No | DISCN | BIODELIVERY SCIENCES INTERNATIONAL INC | bcd18c59cafe41e1940565b279daf22c9c88d980d6e3d8fd2cba1d8a94a84abf |
| 6655 | N | 205637 | 002 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL | FILM | BUCCAL | BUNAVAIL | BDSI | EQ 4.2MG BASE;EQ 0.7MG BASE | | [] | 2014-06-06 | Jun 6, 2014 | No | Yes | No | DISCN | BIODELIVERY SCIENCES INTERNATIONAL INC | c5a96a4ce8a84557f253d0e8d41cfea5849f5be89c752a6059b3c2f1c1c3b9d6 |
| 6656 | N | 205637 | 003 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL | FILM | BUCCAL | BUNAVAIL | BDSI | EQ 6.3MG BASE;EQ 1MG BASE | | [] | 2014-06-06 | Jun 6, 2014 | No | Yes | No | DISCN | BIODELIVERY SCIENCES INTERNATIONAL INC | c9d3ebbbd6dcc3eefcafe05781cdc277ad662160620961a3b1a3c3861207b6a6 |
| 6657 | N | 022266 | 001 | FENTANYL CITRATE | FILM;BUCCAL | FILM | BUCCAL | ONSOLIS | BDSI | EQ 0.2MG BASE | | [] | 2009-07-16 | Jul 16, 2009 | No | No | No | DISCN | BIODELIVERY SCIENCES INTERNATIONAL INC | b1a2b3a571c5022aa643c72efca685922377f73243e9470b9cf6f51e06a1814a |
| 6658 | N | 022266 | 002 | FENTANYL CITRATE | FILM;BUCCAL | FILM | BUCCAL | ONSOLIS | BDSI | EQ 0.4MG BASE | | [] | 2009-07-16 | Jul 16, 2009 | No | No | No | DISCN | BIODELIVERY SCIENCES INTERNATIONAL INC | 13e790614e62bc9f2b679f74fcfbc7ed030e354a6bb147649798ddfb107f16aa |
| 6659 | N | 022266 | 003 | FENTANYL CITRATE | FILM;BUCCAL | FILM | BUCCAL | ONSOLIS | BDSI | EQ 0.6MG BASE | | [] | 2009-07-16 | Jul 16, 2009 | No | No | No | DISCN | BIODELIVERY SCIENCES INTERNATIONAL INC | 7fc9ecab4b87aba5ca97ce24fc5ca549175e0d287dd9d0288fd38baff6667dde |
| 6660 | N | 022266 | 004 | FENTANYL CITRATE | FILM;BUCCAL | FILM | BUCCAL | ONSOLIS | BDSI | EQ 0.8MG BASE | | [] | 2009-07-16 | Jul 16, 2009 | No | No | No | DISCN | BIODELIVERY SCIENCES INTERNATIONAL INC | 62a7549cfbe96c59b883218dbaba71bae46738f6a7fe0d8e4d6333bb0a03cf46 |
| 6661 | N | 022266 | 005 | FENTANYL CITRATE | FILM;BUCCAL | FILM | BUCCAL | ONSOLIS | BDSI | EQ 1.2MG BASE | | [] | 2009-07-16 | Jul 16, 2009 | No | No | No | DISCN | BIODELIVERY SCIENCES INTERNATIONAL INC | d752ad332c052b18cc0520e7507a166ceee7f36a9522e54576717f2ec019c4d5 |
| 6662 | A | 205954 | 001 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL, SUBLINGUAL | FILM | BUCCAL, SUBLINGUAL | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | ALVOGEN PINE BROOK | EQ 2MG BASE;EQ 0.5MG BASE | AB | ["AB"] | 2019-01-24 | Jan 24, 2019 | No | No | No | RX | ALVOGEN PINE BROOK LLC | 32f5c80b2126bc17df3fbc3e97745536d6480ed7202bbcba1ee86a37b51573f2 |
| 6663 | A | 205954 | 002 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL, SUBLINGUAL | FILM | BUCCAL, SUBLINGUAL | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | ALVOGEN PINE BROOK | EQ 4MG BASE;EQ 1MG BASE | AB | ["AB"] | 2019-01-24 | Jan 24, 2019 | No | No | No | RX | ALVOGEN PINE BROOK LLC | c4b42e26fee84576ad3d510f731bfbd94c5b9faf9c2656cf7684a58fc5390e8d |
| 6664 | A | 205954 | 003 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL, SUBLINGUAL | FILM | BUCCAL, SUBLINGUAL | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | ALVOGEN PINE BROOK | EQ 8MG BASE;EQ 2MG BASE | AB | ["AB"] | 2019-01-24 | Jan 24, 2019 | No | No | No | RX | ALVOGEN PINE BROOK LLC | e4b3ac7debd9e37ea49bca7fe7656b022271c6ca4f367e54b68651c193ad140f |
| 6665 | A | 205954 | 004 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL, SUBLINGUAL | FILM | BUCCAL, SUBLINGUAL | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | ALVOGEN PINE BROOK | EQ 12MG BASE;EQ 3MG BASE | AB | ["AB"] | 2019-01-24 | Jan 24, 2019 | No | No | No | RX | ALVOGEN PINE BROOK LLC | afd38445ecb8806feb8975f1a3a240f17c6f7f4cc5d71fb078ff744a042c964a |
| 6666 | A | 205299 | 001 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL, SUBLINGUAL | FILM | BUCCAL, SUBLINGUAL | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | DR REDDYS LABS SA | EQ 2MG BASE;EQ 0.5MG BASE | AB | ["AB"] | 2018-06-14 | Jun 14, 2018 | No | No | No | RX | DR REDDYS LABORATORIES SA | 515c7b9c8adc5735958e4df7802da7b4681b375b82256128b582029841647cab |
| 6667 | A | 205806 | 001 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL, SUBLINGUAL | FILM | BUCCAL, SUBLINGUAL | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | DR REDDYS LABS SA | EQ 4MG BASE;EQ 1MG BASE | AB | ["AB"] | 2018-06-14 | Jun 14, 2018 | No | No | No | RX | DR REDDYS LABORATORIES SA | 358734a266c3b6450f4f8ee6617f4c71fa28f4a0410cd232bbfeb454c39d4c1c |
| 6668 | A | 205299 | 002 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL, SUBLINGUAL | FILM | BUCCAL, SUBLINGUAL | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | DR REDDYS LABS SA | EQ 8MG BASE;EQ 2MG BASE | AB | ["AB"] | 2018-06-14 | Jun 14, 2018 | No | No | No | RX | DR REDDYS LABORATORIES SA | 1091bd20fca9ef9c464e1ffb2f776c5d97c841443b67003ed3670c77a53b64f7 |
| 6669 | A | 205806 | 002 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL, SUBLINGUAL | FILM | BUCCAL, SUBLINGUAL | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | DR REDDYS LABS SA | EQ 12MG BASE;EQ 3MG BASE | AB | ["AB"] | 2018-06-14 | Jun 14, 2018 | No | No | No | RX | DR REDDYS LABORATORIES SA | bd936066b7190ac8bad38572ea4bbac3b81049a636470f7fa4feb8fed796ef20 |
| 6670 | A | 211785 | 001 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL, SUBLINGUAL | FILM | BUCCAL, SUBLINGUAL | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | MYLAN TECHNOLOGIES | EQ 2MG BASE;EQ 0.5MG BASE | AB | ["AB"] | 2020-04-17 | Apr 17, 2020 | No | No | No | RX | MYLAN TECHNOLOGIES INC | 90a71423c8fe413faec7e6556a23d40bfd59283447fa6e222ff6f16df1f82f86 |
| 6671 | A | 211785 | 002 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL, SUBLINGUAL | FILM | BUCCAL, SUBLINGUAL | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | MYLAN TECHNOLOGIES | EQ 4MG BASE;EQ 1MG BASE | AB | ["AB"] | 2020-04-17 | Apr 17, 2020 | No | No | No | RX | MYLAN TECHNOLOGIES INC | 3b4fb31b9c6b258ac3851c62cf0871c3116b7ac98f937e59c44f487c47ef7e9e |
| 6672 | A | 207607 | 001 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL, SUBLINGUAL | FILM | BUCCAL, SUBLINGUAL | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | MYLAN TECHNOLOGIES | EQ 8MG BASE;EQ 2MG BASE | AB | ["AB"] | 2018-06-14 | Jun 14, 2018 | No | No | No | RX | MYLAN TECHNOLOGIES INC | bb66e73bdd0e1c36265fa51bcf92f1dd04e3b84bfe0ce1d5a157a65f0b87883f |
| 6673 | A | 207607 | 002 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL, SUBLINGUAL | FILM | BUCCAL, SUBLINGUAL | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | MYLAN TECHNOLOGIES | EQ 12MG BASE;EQ 3MG BASE | AB | ["AB"] | 2018-06-14 | Jun 14, 2018 | No | No | No | RX | MYLAN TECHNOLOGIES INC | 24fb8b541352d2a5d1bd637c1134272f66b8450e69e6a4fc56d8c19b2a60173e |
| 6674 | N | 022410 | 001 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL, SUBLINGUAL | FILM | BUCCAL, SUBLINGUAL | SUBOXONE | INDIVIOR INC | EQ 2MG BASE;EQ 0.5MG BASE | AB | ["AB"] | 2010-08-30 | Aug 30, 2010 | No | Yes | No | RX | INDIVIOR INC | adf71cd012abf46a74de76557321e102419a76ee4a71bf41bfcf4e4dd1dd7674 |
| 6675 | N | 022410 | 003 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL, SUBLINGUAL | FILM | BUCCAL, SUBLINGUAL | SUBOXONE | INDIVIOR INC | EQ 4MG BASE;EQ 1MG BASE | AB | ["AB"] | 2012-08-10 | Aug 10, 2012 | No | Yes | No | RX | INDIVIOR INC | 0a1ccfbf518d3bb140dc94092a2f593b760689d11bbcf680dc2965cdf9db5282 |
| 6676 | N | 022410 | 002 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL, SUBLINGUAL | FILM | BUCCAL, SUBLINGUAL | SUBOXONE | INDIVIOR INC | EQ 8MG BASE;EQ 2MG BASE | AB | ["AB"] | 2010-08-30 | Aug 30, 2010 | No | Yes | No | RX | INDIVIOR INC | 235a71ab1d4dc9f8d71fa4ac0a13081a8b1cdf075801c281135d08c4a6d4d1bb |
| 6677 | N | 022410 | 004 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;BUCCAL, SUBLINGUAL | FILM | BUCCAL, SUBLINGUAL | SUBOXONE | INDIVIOR INC | EQ 12MG BASE;EQ 3MG BASE | AB | ["AB"] | 2012-08-10 | Aug 10, 2012 | No | Yes | Yes | RX | INDIVIOR INC | 8d179ac8caf4fd387ac2be66642fcc521a2788b4b75ed6d2efb6004b912a75d0 |
| 6678 | N | 212640 | 001 | RILUZOLE | FILM;ORAL | FILM | ORAL | EXSERVAN | MITSUBISHI HOLDINGS | 50MG | | [] | 2019-11-22 | Nov 22, 2019 | No | Yes | Yes | RX | MITSUBISHI TANABE PHARMA HOLDINGS AMERICA INC | 83e6f54a30acec16df553e3c4b976dbf4f80ca601f1dd9016a99375c5dbee01f |
| 6679 | N | 022470 | 001 | KETOPROFEN | FILM;ORAL | FILM | ORAL | NEXCEDE | NOVARTIS | 12.5MG | | [] | 2009-11-25 | Nov 25, 2009 | No | No | No | DISCN | NOVARTIS CONSUMER HEALTH INC | 17eadf57550f97116df6a31d148fc6d1c964b13eaf008a849c57e3b063e889fe |
| 6680 | N | 210833 | 001 | CLOBAZAM | FILM;ORAL | FILM | ORAL | SYMPAZAN | AQUESTIVE | 5MG | | [] | 2018-11-01 | Nov 1, 2018 | No | Yes | No | RX | AQUESTIVE THERAPEUTICS INC | e110096b96e5b8a15b6868996d435b732868cfb5076952c5f8bb861a83489bc3 |
| 6681 | N | 210833 | 002 | CLOBAZAM | FILM;ORAL | FILM | ORAL | SYMPAZAN | AQUESTIVE | 10MG | | [] | 2018-11-01 | Nov 1, 2018 | No | Yes | No | RX | AQUESTIVE THERAPEUTICS INC | 1328d9f115a4edf0152e05c9e30a18d084b39d22e271a24c1911270916422a69 |
| 6682 | N | 210833 | 003 | CLOBAZAM | FILM;ORAL | FILM | ORAL | SYMPAZAN | AQUESTIVE | 20MG | | [] | 2018-11-01 | Nov 1, 2018 | No | Yes | Yes | RX | AQUESTIVE THERAPEUTICS INC | 0fd2129036c72317311fb37d224de3422bd5991b3ccded2719098471ec6ceba0 |
| 6683 | N | 022524 | 001 | ONDANSETRON | FILM;ORAL | FILM | ORAL | ZUPLENZ | AQUESTIVE | 4MG | | [] | 2010-07-02 | Jul 2, 2010 | No | Yes | No | DISCN | AQUESTIVE THERAPEUTICS INC | 3e6344c36f1930ce15e1ac6d0346dc15cb8db63a186a500e1c5cf8bbfc89f53c |
| 6684 | N | 022524 | 002 | ONDANSETRON | FILM;ORAL | FILM | ORAL | ZUPLENZ | AQUESTIVE | 8MG | | [] | 2010-07-02 | Jul 2, 2010 | No | Yes | No | DISCN | AQUESTIVE THERAPEUTICS INC | a36017ce742b2e8c6636a5cf6edbc597374de32dca4ed95ee9a7efc44cdc503b |
| 6685 | N | 208042 | 001 | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE | FILM;SUBLINGUAL | FILM | SUBLINGUAL | CASSIPA | TEVA PHARMS USA | EQ 16MG BASE;EQ 4MG BASE | | [] | 2018-09-07 | Sep 7, 2018 | No | Yes | No | DISCN | TEVA PHARMACEUTICALS USA INC | 0679a633e044296d104032baa8f14ac19611e743089718200edd69532a05d8d9 |
| 6686 | N | 210875 | 001 | APOMORPHINE HYDROCHLORIDE | FILM;SUBLINGUAL | FILM | SUBLINGUAL | KYNMOBI | SUNOVION PHARMS INC | 10MG | | [] | 2020-05-21 | May 21, 2020 | No | Yes | No | RX | SUNOVION PHARMACEUTICALS INC | d76456e6296d0735d88c89d9b7ecab02e3fa280b74042dc25501e58a61df535b |
| 6687 | N | 210875 | 002 | APOMORPHINE HYDROCHLORIDE | FILM;SUBLINGUAL | FILM | SUBLINGUAL | KYNMOBI | SUNOVION PHARMS INC | 15MG | | [] | 2020-05-21 | May 21, 2020 | No | Yes | No | RX | SUNOVION PHARMACEUTICALS INC | 5513136889c37bb040a3c7f0534b007198a9228f704358981d87331b46e03191 |
| 6688 | N | 210875 | 003 | APOMORPHINE HYDROCHLORIDE | FILM;SUBLINGUAL | FILM | SUBLINGUAL | KYNMOBI | SUNOVION PHARMS INC | 20MG | | [] | 2020-05-21 | May 21, 2020 | No | Yes | No | RX | SUNOVION PHARMACEUTICALS INC | 2fa43e56f9be8b9237af1b1e0b6728feba0ce074adaa563a2d88b83290711f2a |
| 6689 | N | 210875 | 004 | APOMORPHINE HYDROCHLORIDE | FILM;SUBLINGUAL | FILM | SUBLINGUAL | KYNMOBI | SUNOVION PHARMS INC | 25MG | | [] | 2020-05-21 | May 21, 2020 | No | Yes | No | RX | SUNOVION PHARMACEUTICALS INC | 9725cf5e4e32b1c3a24a6946e219e9e081c176cf170bb214d512d61a5eee158a |
| 6690 | N | 210875 | 005 | APOMORPHINE HYDROCHLORIDE | FILM;SUBLINGUAL | FILM | SUBLINGUAL | KYNMOBI | SUNOVION PHARMS INC | 30MG | | [] | 2020-05-21 | May 21, 2020 | No | Yes | Yes | RX | SUNOVION PHARMACEUTICALS INC | f9cf0a397c3b54c226c4f802d9788d0328fbb141b6673d859b478008e9ac7cb5 |
| 6691 | N | 212279 | 001 | AIR POLYMER-TYPE A | FOAM;INTRAUTERINE | FOAM | INTRAUTERINE | EXEM FOAM KIT | GISKIT | 10ML | | [] | 2019-11-07 | Nov 7, 2019 | No | Yes | Yes | RX | GISKIT BV | 1383d6b5d9914ad9ebff725d735cffbfeb9647c5cd322ed3ad05d3201102b316 |
| 6692 | N | 021551 | 003 | BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE | FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL | FOR SOLUTION, TABLET, DELAYED RELEASE | ORAL | HALFLYTELY | BRAINTREE | 5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM;N/A,5.6GM **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 2010-07-16 | Jul 16, 2010 | No | Yes | No | DISCN | BRAINTREE LABORATORIES INC | 18a02028fb3e029b284a4824f647d8327f545569e2b92928cfb1d4088958091d |
| 6693 | A | 202217 | 001 | BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE | FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL | FOR SOLUTION, TABLET, DELAYED RELEASE | ORAL | PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL | NOVEL LABS INC | 5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM;N/A,5.6GM | | [] | 2014-08-20 | Aug 20, 2014 | No | No | No | DISCN | NOVEL LABORATORIES INC | b40a652579f74ab8e921c3b0d8fe3cedae63b969ca6382e7a7c5bf145f971ba5 |
| 6694 | N | 021314 | 001 | CITRIC ACID; UREA C-13 | FOR SOLUTION, TABLET, FOR SOLUTION;ORAL | FOR SOLUTION, TABLET, FOR SOLUTION | ORAL | IDKIT:HP | EXALENZ BIOSCIENCE | N/A,4GM;75MG,N/A | | [] | 2002-12-17 | Dec 17, 2002 | No | Yes | Yes | RX | EXALENZ BIOSCIENCE LTD | dbc62325dbbf1241c4d029d1d55f90699b93fde5ea0b543a7b3dbe3197b981bb |
| 6695 | N | 050814 | 001 | AZTREONAM | FOR SOLUTION;INHALATION | FOR SOLUTION | INHALATION | CAYSTON | GILEAD | 75MG/VIAL | | [] | 2010-02-22 | Feb 22, 2010 | No | Yes | Yes | RX | GILEAD SCIENCES INC | 884db20f3408cc7bf14b23629e16caba97ce67ba9c49dead8e2b92f4965886f7 |
| 6696 | N | 019887 | 001 | PENTAMIDINE ISETHIONATE | FOR SOLUTION;INHALATION | FOR SOLUTION | INHALATION | NEBUPENT | FRESENIUS KABI USA | 300MG/VIAL | AN | ["AN"] | 1989-06-15 | Jun 15, 1989 | No | Yes | Yes | RX | FRESENIUS KABI USA LLC | aebc028d9225c76b5c8158bdf7e2fb34436d7c13d9078dd2362c80e2abe5d78b |
| 6697 | N | 019887 | 002 | PENTAMIDINE ISETHIONATE | FOR SOLUTION;INHALATION | FOR SOLUTION | INHALATION | NEBUPENT | FRESENIUS KABI USA | 600MG/VIAL | | [] | 1996-03-22 | Mar 22, 1996 | No | No | No | DISCN | FRESENIUS KABI USA LLC | a133ed8a7edf80d711cbbf57c1386b9812b1c950ab78617f6589402ab1b998fa |
| 6698 | A | 206667 | 001 | PENTAMIDINE ISETHIONATE | FOR SOLUTION;INHALATION | FOR SOLUTION | INHALATION | PENTAMIDINE ISETHIONATE | SETON PHARMS | 300MG/VIAL | AN | ["AN"] | 2019-04-24 | Apr 24, 2019 | No | No | No | RX | SETON PHARMACEUTICALS LLC | 315a4735514cd6ca26d727907ba7aaeb9594759f25d62b16bbfb8f3eb6924011 |
| 6699 | N | 019193 | 001 | METHACHOLINE CHLORIDE | FOR SOLUTION;INHALATION | FOR SOLUTION | INHALATION | PROVOCHOLINE | METHAPHARM | 100MG/VIAL | | [] | 1986-10-31 | Oct 31, 1986 | No | Yes | Yes | RX | METHAPHARM INC | 8d42f23045365c074ad3aecb988b66a3d926aea8d4e535bdf4c62725358b60c9 |
| 6700 | N | 019193 | 002 | METHACHOLINE CHLORIDE | FOR SOLUTION;INHALATION | FOR SOLUTION | INHALATION | PROVOCHOLINE | METHAPHARM | 1600MG/VIAL | | [] | 2016-08-29 | Aug 29, 2016 | No | Yes | No | DISCN | METHAPHARM INC | 4eb65157c7cfb3cf022a1b401a83a8ceab7f054d8a6b6e8d289f6bcb0e1c6dbe |
| 6701 | A | 207366 | 001 | RIBAVIRIN | FOR SOLUTION;INHALATION | FOR SOLUTION | INHALATION | RIBAVIRIN | NAVINTA LLC | 6GM/VIAL | AN | ["AN"] | 2016-10-06 | Oct 6, 2016 | No | No | No | RX | NAVINTA LLC | c72dc5f6db0c2990f467f0d27b92659012230b6ac7a5338ae4c11b63413a8671 |